EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Efficacy and Safety of Low‐Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo‐Controlled, Double‐Blind, Clinical Trial

Himanshu Prajapati, Milan Satia, Dhara Shah, Ishita Basera, Tanvi Shah

Phytotherapy Research · 2026-08 · 40 (8) · 4978-4987

DOI: 10.1002/ptr.70178 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Phytotherapy Research, online erschienen am 17.03.2026. Verfasst von Himanshu Prajapati und 4 weiteren Autor:innen. Beteiligte Einrichtung: Prajna Health Care, Ahmedabad, India. Hauptthemen laut MEDLINE: Withania, Dietary Supplements, Plant Extracts, Exercise. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Remedies Pvt. Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ashwagandha ( Withania somnifera ) is a well‐known adaptogen with established roles in stress modulation and physical performance enhancement traditionally. Low dose Ashwagandha (LDA/Ashwa.30) is a bioactive‐optimized root‐only extract standardized to withanolides (> 15% w/w) and an ATP‐active fraction (> 15% w/w). This study investigated the efficacy and safety of LDA supplementation on cardiorespiratory fitness and exercise‐induced fatigue in healthy individuals. In this eight‐week, randomized, double‐blind, placebo‐controlled study, healthy adults received either LDA (30 mg/day) or placebo. VO 2 max was assessed as primary endpoint using an indirect method via the Modified Bruce Protocol Treadmill Test (MBPTT). Secondary endpoints included lactic acid, creatine phosphokinase (CPK), Rating of Perceived Exertion (RPE), fatigue scores (VAS), and safety biomarkers. LDA significantly improved VO 2 max and maximal heart rate compared to the placebo. Participants in the treatment group showed lower lactic acid levels at exercise, indicating prolonged aerobic metabolism. CPK levels were significantly reduced, suggesting mitigation of muscle energy stress. Borg RPE and fatigue scores improved in the LDA group. LDA was well tolerated, with no treatment‐related adverse events. Hematological, hepatic, renal, metabolic, and vital sign parameters remained within normal clinical ranges following intake of LDA. LDA supplementation for 8 weeks significantly enhanced cardiorespiratory fitness, delayed fatigue onset, and was safe for use in healthy adults. These findings support its potential as a safe and effective low‐dose aid for endurance enhancement and overall exercise performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WithaniaDietary SupplementsPlant ExtractsExercisePhysical EnduranceHumansDouble-Blind MethodAdultFemaleMaleOxygen ConsumptionCreatine KinaseLactic AcidFatigueYoung AdultExercise TestHeart RateCardiorespiratory Fitness

Stichwörter der Autor:innen

Withania somniferaVO2maxashwagandhafatiguelow‐dosesafety

Substanzen

AshwagandhaPlant ExtractsCreatine KinaseLactic Acid

Autor:innen und Institutionen

  • Prajna Health Care, Ahmedabad, India.
  • Ethicare Clinical Trial Services (OPC) Pvt. Ltd., Ahmedabad, India.

Förderung

  • Natural Remedies Pvt. Ltd.

Zitieren

APA

Prajapati, H., Satia, M., Shah, D., Basera, I., & Shah, T. (2026). Efficacy and Safety of Low‐Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo‐Controlled, Double‐Blind, Clinical Trial. Phytotherapy Research, 40(8), 4978-4987. https://doi.org/10.1002/ptr.70178

Vancouver

Prajapati H, Satia M, Shah D, Basera I, Shah T. Efficacy and Safety of Low‐Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo‐Controlled, Double‐Blind, Clinical Trial. Phytotherapy Research. 2026;40(8):4978-4987. doi:10.1002/ptr.70178

BibTeX
@article{Prajapati2026,
  author = {Prajapati, Himanshu and Satia, Milan and Shah, Dhara and Basera, Ishita and Shah, Tanvi},
  title = {Efficacy and Safety of Low‐Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo‐Controlled, Double‐Blind, Clinical Trial},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {8},
  pages = {4978--4987},
  doi = {10.1002/ptr.70178}
}
Kostenlos starten →